Customer Letters

Please note: The following Customer Letters, do not replace the version that you receive from your local Canadian Blood Services site.

* The contents of the customer letters available on this site are current as of their dates of publication. If required, contact your local Hospital Liaison Specialist to determine if the letter is still current.

Displaying 301 - 350 of 398

	Date Sort ascending
CL_2018-49.pdf	2018-12-19	INFORMATION ONLY CUVITRU® Inventory Update Customer Letter 2018-49 (PDF) \| Dear Customer Letter re CUVITRU
CL 2018-47	2018-12-06	INFORMATION ONLY Changes Planned Over the December 8th Weekend – Product and Service Impacts Customer Letter 2018-47 (PDF)
CL_2018-46.pdf	2018-11-19	INFORMATION ONLY Routine K1 (Kell) Phenotype Testing Customer Letter 2018-46 (PDF)
CL_2018-45_Corrected.pdf	2018-11-14	INFORMATION ONLY CORRECTED - HLA/HPA Testing Process Customer Letter 2018-45 (PDF)
CL 2018-44.pdf	2018-11-14	INFORMATION ONLY Updated Blood System Inventory Management Best Practices Guide Customer Letter 2018-44 (PDF)
CL_2018-43.pdf	2018-11-05	INFORMATION ONLY Release of Revised Circular of Information for Red Blood Cells Customer Letter 2018-43 (PDF)
CL_2018-42.pdf	2018-10-17	INFORMATION ONLY Donation Number Label Change Customer Letter 2018-42 (PDF)
CL_2018-41.pdf	2018-10-04	INFORMATION ONLY Now Posted - NAC Endorsement of the ICTMG Platelet Guidelines Customer Letter 2018-41 (PDF)
CL_2018-40.pdf	2018-10-02	INFORMATION ONLY Revision - Availability of Immune Globulin Products for 2018-2019 Customer Letter 2018-40 (PDF)
CL_2018-39.pdf	2018-10-01	ACTION REQUIRED HLA/HPA Testing Process Customer Letter 2018-39 (PDF)
CL_2018-38.pdf	2018-09-24	INFORMATION ONLY Revision to the IgA/Anti-IgA Patient Request Form Customer Letter 2018-38 (PDF)
CL_2018-37.pdf	2018-09-05	ACTION REQUIRED HLA/HPA Request Process Update Customer Letter 2018-37 (PDF)
CL_2018-36.pdf	2018-09-04	INFORMATION ONLY RHCE and Extended Blood Group Genotyping for Alberta Hospitals Customer Letter 2018-36 (PDF)
CL_2018-35.pdf	2018-08-23	ACTION REQUIRED Subcutaneous Immune Globulin Transition Update Customer Letter 2018-35 (PDF)
CL_2018-34.pdf	2018-08-20	ACTION REQUIRED Requesting Eloctate and Alprolix for Eligible Patients Customer Letter 2018-34 (PDF) \| F801219 - sample
CL_2018-33.pdf	2018-08-16	INFORMATION ONLY Now Posted – Recommendations for the Use of Irradiated Blood Components in Canada Customer Letter 2018-33 (PDF)
CL2018-32.pdf	2018-08-15	INFORMATION ONLY Plasma Protein Products Transition Newsletter – August 2018 Customer Letter 2018-32 (PDF) \| Plasma Protein Products Transition Newsletter – August 2018
CL_2018-31.pdf	2018-08-07	INFORMATION ONLY Nuwiq 3000 IU and 4000 IU Vial Sizes Available for Distribution Customer Letter 2018-31 (PDF) \| Octapharma - Nuwiq 3000 IU and 4000 IU Vial Sizes Available for Distribution
CL_2018-30.pdf	2018-07-31	INFORMATION ONLY Release of Revised Circulars of Information for Red Blood Cells, Platelets, and Plasma Customer Letter 2018-30 (PDF)
CL_2018-29.pdf	2018-07-10	INFORMATION ONLY Canadian Babesiosis Study Customer Letter 2018-29 (PDF)
CL_2018-28.pdf	2018-07-04	INFORMATION ONLY Planned Changes to the Hospital Feedback Process Customer Letter 2018-28 (PDF)
CL_2018-27.pdf	2018-06-25	INFORMATION ONLY Plasma Protein Products Transition Newsletter – June 2018 Customer Letter 2018-27(PDF) \| Plasma Protein Products Transition Newsletter – June 2018
CL_2018-26.pdf	2018-06-21	INFORMATION ONLY Introduction of Fresenius Kabi Platelets, Pooled Storage Container Customer Letter 2018-26 (PDF)
CL_2018-25.pdf	2018-06-21	INFORMATION ONLY Privigen® 20g (10%) Lot 4357600032 Distribution Hold Cancellation Customer Letter 2018-25 (PDF) \| Privigen® 20g (10%) Lot 4357600032 Distribution Hold Cancellation
CL_2018-24.pdf	2018-06-19	INFORMATION ONLY New Packaging for CSL Behring Products Customer Letter 2018-24 (PDF) \| New Packaging for Berinert®, Beriplex® PN, Corifact®, Humate-P® and RiaSTAP® (PDF)
CL_2018-23_PPP_Trend_Reports.pdf	2018-06-18	INFORMATION ONLY Launch of Hospital Plasma Protein Product Disposition Trend Graphs Customer Letter 2018-23 (PDF)
CL_2018-22.pdf	2018-06-11	INFORMATION ONLY Canadian Blood Services – Diagnostic Services Revised Web Pages Customer Letter 2018-22 (PDF)
CL_2018-21.pdf	2018-05-28	INFORMATION ONLY Qualification Information - New Insulated Shipping Containers for Hospital Deliveries Attachment_1_CL_2018-21.pdf \| Attachment_2_CL_2018-21.pdf
CL_2018-20.pdf	2018-05-17	INFORMATION ONLY Plasma Protein Products Transition Newsletter – May 2018 PPP_Transition_Newsletter_May_2018.pdf
CL_2018-19.pdf	2018-05-08	INFORMATION ONLY New Factor Products now available from Canadian Blood Services Novo-Nordisk-HC-approves-Rebinyn.pdf \| Shire-Adynovate-available-CBS.pdf
CL_2018-18.pdf	2018-04-26	INFORMATION ONLY Cuvitru and Gammagard Liquid now available from Canadian Blood Services Shire_Customer_Letter_-_Cuvitru_20_will_soon_be_available_through_Canadian_Blood_Services.pdf
CL_2018-17.pdf	2018-04-25	INFORMATION ONLY Plasma Protein Products Manufacturer Updates (CSL Behring, Octapharma and Grifols) CSL_Behring_Notification_of_Change_to_Lot_Numbering_Structure.pdf \| Octapharma_Octaplex_now_Available_with_3_Year_Shelf_Life.pdf \| Grifols_Important_Changes_in_Recomended_Dosage_Instructions_for_GamaSTAN_SD.pdf \| Grifols_Change_in_Appearance_of_Pre-filled_Syringes_for_HyperHep_B_SD.pdf
CL_2018-16.pdf	2018-04-21	INFORMATION ONLY Follow-up to Production Announcement – Transfer of Regina Production Activities to Calgary Customer Letter 2018-16 (PDF)
CL_2018-15.pdf	2018-04-16	INFORMATION ONLY Availability of Immune Globulin Products for 2018-2019 Customer Letter 2018-15 (PDF)
CL_2018-14.pdf	2018-04-03	INFORMATION ONLY Plasma Protein Products Transition Newsletter – March 2018 Customer Letter 2018-14 (PDF) PPP_Transition_March_2018_Newsletter.pdf
CL_2018-13.pdf	2018-03-20	INFORMATION ONLY Introduction of Rare Blood Program Customer Letter 2018-13 (PDF)
CL_2018-12.pdf	2018-03-12	INFORMATION ONLY Further Information; Health Canada Approval, Changes to Red Blood Cell Extended Antigen Printing on the End Label Customer Letter 2018-12 (PDF)
CL_2018-11.pdf	2018-03-01	INFORMATION ONLY Implementation Update: Increase in Collections of ACD-A Apheresis Fresh Frozen Plasma and New ISBT Component Codes Customer Letter 2018-11 (PDF)
CL_2018-_10.pdf	2018-02-28	INFORMATION ONLY Plasma Protein Products Transition Newsletter – February 2018 Customer Letter 2018-10 (PDF) Feb_2018_Newsletter_EN.pdf
CL_2018-09.pdf	2018-02-27	INFORMATION ONLY Introduction of coloured dots on some of our blood components Customer Letter 2018-09 (PDF)
CL_2018-08.pdf	2018-02-15	INFORMATION ONLY Grifols’ Albumin (Human) 5% and 25% – Low Aluminum Customer Letter 2018-08 (PDF) Grifols_Customer_Letter_2018-02-15.pdf
CL_2018-07.pdf	2018-02-05	INFORMATION ONLY OBIZUR now available from Canadian Blood Services Customer Letter 2018-07 (PDF) Shire-Healthcare_Professionals_Letter.pdf
CL_2018-06.pdf	2018-01-30	INFORMATION ONLY Release of Companion Components Associated with a Confirmed Negative Bacterial Screening Test Customer Letter 2018-06 (PDF)
CL_2018-05.pdf	2018-01-29	INFORMATION ONLY Factor XI Concentrate Inventory Alert Customer Letter 2018-05 (PDF)
CL_2018-04.pdf	2018-01-26	INFORMATION ONLY Plasma Protein Products Transition Newsletter – January 2018 Customer Letter 2018-04 (PDF)
CL_2018-03.pdf	2018-01-23	INFORMATION ONLY Release of Revised Circular of Information for Plasma Components Customer Letter 2018-03 (PDF)
CL_2018-02.pdf	2018-01-22	INFORMATION ONLY Notification of Change of Site for IgA Program Customer Letter 2018-02 (PDF) IgA_anti-IgA_Patient-request-form.pdf
CL_2018-01.pdf	2018-01-18	INFORMATION ONLY Revisions to the Special Request Order Form Customer Letter 2018-01 (PDF)
CL_2017-48.pdf	2017-12-28	ACTION REQUIRED Increase in Collection of ACD-A Apheresis Fresh Frozen Plasma and New ISBT Component Codes
CL_2017-47.pdf	2017-12-21	INFORMATION ONLY 2017 Holiday Message and Inventory Update